Free Trial

Athira Pharma (ATHA) SEC Filings & 10K Form

Athira Pharma logo
$0.63
+0.02 (+3.99%)
(As of 12:49 PM ET)

Recent Athira Pharma SEC Filings

DateFilerForm TypeView
10/31/2024
3:16 PM
Athira Pharma (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13D/A
10/28/2024
11:15 PM
Athira Pharma (Filer)
Form EFFECT
10/21/2024
5:24 AM
Athira Pharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/03/2024
8:50 PM
Athira Pharma (Issuer)
Litton Mark James (Reporting)
Form 4/A
10/03/2024
6:07 PM
Athira Pharma (Issuer)
Litton Mark James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
6:08 PM
Athira Pharma (Issuer)
Worthington Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
6:10 PM
Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
6:13 PM
Athira Pharma (Issuer)
San Martin Javier (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
6:17 PM
Athira Pharma (Issuer)
Renninger Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
6:05 PM
Athira Pharma (Issuer)
Renninger Robert (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/17/2024
8:00 AM
Athira Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
6:47 PM
Athira Pharma (Issuer)
Litton Mark James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:48 PM
Athira Pharma (Issuer)
Worthington Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:49 PM
Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:50 PM
Athira Pharma (Issuer)
Lenington Rachel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:51 PM
Athira Pharma (Issuer)
Gengos Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:53 PM
Athira Pharma (Subject)
Litton Mark James (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
3:15 PM
Athira Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/25/2024
6:21 PM
Athira Pharma (Issuer)
Romano Kelly A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
3:05 PM
Athira Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2024
5:54 PM
Athira Pharma (Issuer)
FLUKE JOHN M JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
5:55 PM
Athira Pharma (Issuer)
PICKERING GRANT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
5:56 PM
Athira Pharma (Issuer)
Panzara Michael A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
5:58 PM
Athira Pharma (Issuer)
Kosacz Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:00 PM
Athira Pharma (Issuer)
JOHNSON JAMES A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:01 PM
Athira Pharma (Issuer)
EDELMAN JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
6:03 PM
Athira Pharma (Issuer)
Romano Kelly A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
3:34 PM
Athira Pharma (Issuer)
San Martin Javier (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/16/2024
3:37 PM
Athira Pharma (Issuer)
San Martin Javier (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
7:32 AM
Athira Pharma (Filer)
Form DEF 14A
04/09/2024
7:34 AM
Athira Pharma (Filer)
Form DEFA14A
04/09/2024
7:35 AM
Athira Pharma (Filer)
Form ARS
03/28/2024
7:47 AM
Athira Pharma (Filer)
Form PRE 14A
02/22/2024
3:34 PM
Athira Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/22/2024
3:15 PM
Athira Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/16/2024
3:46 PM
Athira Pharma (Issuer)
Lenington Rachel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:48 PM
Athira Pharma (Issuer)
Gengos Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:54 PM
Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:32 PM
Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
Form 4/A
02/16/2024
3:34 PM
Athira Pharma (Issuer)
Gengos Andrew (Reporting)
Form 4/A
02/16/2024
3:37 PM
Athira Pharma (Issuer)
Worthington Mark (Reporting)
Form 4/A
This is treason (Ad)

If you missed it, my emergency election broadcast is now available - but will be removed soon

02/16/2024
3:38 PM
Athira Pharma (Issuer)
Litton Mark James (Reporting)
Form 4/A
02/16/2024
3:40 PM
Athira Pharma (Issuer)
Lenington Rachel (Reporting)
Form 4/A
01/08/2024
3:36 PM
Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:38 PM
Athira Pharma (Issuer)
Worthington Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:40 PM
Athira Pharma (Issuer)
Litton Mark James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:42 PM
Athira Pharma (Issuer)
Gengos Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:45 PM
Athira Pharma (Issuer)
MOEBIUS HANS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:35 PM
Athira Pharma (Issuer)
Lenington Rachel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
6:11 AM
Athira Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
4:24 PM
Athira Pharma (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
4:15 PM
Athira Pharma (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13D/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ATHA) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners